A UCLA-led study published in Gastroenterology found that fewer than 50% of average-risk adults with abnormal results from Guardant Health’s…
Browsing: Liquid Biopsy
The FDA has awarded breakthrough device designation to Quest Diagnostics’ Haystack MRD test, a highly sensitive ctDNA assay designed for…
Background: A faecal immunochemical test (FIT) result ≥ 10 μg/g is recommended in the UK to triage patientswith symptoms of…
Geneoscopy, Inc. announced that Exact Sciences has withdrawn its motion for a preliminary injunction tied to two patents (’781 and…
The article discusses the establishment of the Cancer Screening Research Network by the U.S. National Institutes of Health (NIH). This…
Getlabs, a leader in at-home diagnostics, has announced the addition of GRAIL’s GalleriⓇ multi-cancer early detection test to its suite…
Healthcare services company Curative Insurance Company and GRAIL, a healthcare company whose mission is to detect cancer early when it…
Delfi Diagnostics has put forward a new cancer monitoring test that searches the blood for broken pieces of tumor DNA,…
A phase 2/phase 3 clinical trial investigating the efficacy of using circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy in…
At the Gastrointestinal Cancers Symposium in San Francisco, two separate studies presented mixed results regarding the use of liquid biopsy…